Literature DB >> 22586794

Management of cutaneous T-cell lymphoma.

Chris Duhovic1, Fiona Child, E Mary Wain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586794      PMCID: PMC4954104          DOI: 10.7861/clinmedicine.12-2-160

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  8 in total

1.  Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.

Authors:  Madeleine Duvic; Michele Donato; Bouthaina Dabaja; Heather Richmond; Lotika Singh; Wei Wei; Sandra Acholonu; Issa Khouri; Richard Champlin; Chitra Hosing
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

2.  EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

Authors:  Franz Trautinger; Robert Knobler; Rein Willemze; Ketty Peris; Rudolph Stadler; Liliane Laroche; Michel D'Incan; Annamari Ranki; Nicola Pimpinelli; Pablo Ortiz-Romero; Reinhard Dummer; Teresa Estrach; Sean Whittaker
Journal:  Eur J Cancer       Date:  2006-03-30       Impact factor: 9.162

3.  Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Authors:  Nita Sally Agar; Emma Wedgeworth; Siobhan Crichton; Tracey J Mitchell; Michael Cox; Silvia Ferreira; Alistair Robson; Eduardo Calonje; Catherine M Stefanato; Elizabeth Mary Wain; Bridget Wilkins; Paul A Fields; Alan Dean; Katherine Webb; Julia Scarisbrick; Stephen Morris; Sean J Whittaker
Journal:  J Clin Oncol       Date:  2010-09-20       Impact factor: 44.544

4.  A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

Authors:  F J Kaye; P A Bunn; S M Steinberg; J L Stocker; D C Ihde; A B Fischmann; E J Glatstein; G P Schechter; R M Phelps; F M Foss
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

5.  Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

Authors:  Youn H Kim; Howard L Liu; Serena Mraz-Gernhard; Anna Varghese; Richard T Hoppe
Journal:  Arch Dermatol       Date:  2003-07

6.  U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.

Authors:  J J Scarisbrick; P Taylor; U Holtick; Y Makar; K Douglas; G Berlin; E Juvonen; S Marshall
Journal:  Br J Dermatol       Date:  2008-01-30       Impact factor: 9.302

7.  Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

Authors:  S J Whittaker; J R Marsden; M Spittle; R Russell Jones
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

Review 8.  Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Elise Olsen; Eric Vonderheid; Nicola Pimpinelli; Rein Willemze; Youn Kim; Robert Knobler; Herschel Zackheim; Madeleine Duvic; Teresa Estrach; Stanford Lamberg; Gary Wood; Reinhard Dummer; Annamari Ranki; Gunter Burg; Peter Heald; Mark Pittelkow; Maria-Grazia Bernengo; Wolfram Sterry; Liliane Laroche; Franz Trautinger; Sean Whittaker
Journal:  Blood       Date:  2007-05-31       Impact factor: 22.113

  8 in total
  1 in total

1.  Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells.

Authors:  Jiaqi Liu; Jianying Gu; Zihao Feng; Yanhong Yang; Ningwen Zhu; Weiyue Lu; Fazhi Qi
Journal:  J Transl Med       Date:  2016-01-08       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.